127 related articles for article (PubMed ID: 23181274)
1. The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart.
Korolenko TA; Tuzikov FV; Johnston TP; Tuzikova NA; Kisarova YA; Zhanaeva SY; Alexeenko TV; Zhukova NA; Brak IV; Spiridonov VK; Filjushina EE; Cherkanova MS; Monoszon AA
Can J Physiol Pharmacol; 2012 Nov; 90(11):1456-68. PubMed ID: 23181274
[TBL] [Abstract][Full Text] [Related]
2. Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.
Korolenko TA; Tuzikov FV; Cherkanova MS; Johnston TP; Tuzikova NA; Loginova VM; Filjushina EE; Kaledin VI
Can J Physiol Pharmacol; 2012 Feb; 90(2):141-53. PubMed ID: 22320860
[TBL] [Abstract][Full Text] [Related]
3. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
[TBL] [Abstract][Full Text] [Related]
4. Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractions.
Korolenko TA; Johnston TP; Tuzikov FV; Tuzikova NA; Pupyshev AB; Spiridonov VK; Goncharova NV; Maiborodin IV; Zhukova NA
Lipids Health Dis; 2016 Jan; 15():16. PubMed ID: 26801626
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C and chitotriosidase in acute P-407 induced dyslipidemia: Can they serve as potential early biomarkers for atherosclerosis?
Korolenko TA; Pisareva EE; Filyushina EE; Johnston TP; Machova E
Exp Toxicol Pathol; 2015 Sep; 67(9):459-66. PubMed ID: 26129870
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein profile in patients who survive a stroke.
Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
[TBL] [Abstract][Full Text] [Related]
7. [Determination of fractional and subfractional blood lipoprotein compositions with small angle X-ray scattering (a comparison with a biochemical method)].
Tuzikov FV; Ragino IuI; Tuzikova NA; Ivanova MV; Galimov RV; Nikitin IuP
Vopr Med Khim; 2002; 48(1):84-93. PubMed ID: 12068501
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
9. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
10. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
[TBL] [Abstract][Full Text] [Related]
11. The effect of poloxamer 407 on the functional properties of HDL in mice.
Yasuda T; Johnston TP; Shinohara M; Inoue M; Ishida T
J Pharm Pharmacol; 2012 May; 64(5):677-87. PubMed ID: 22471363
[TBL] [Abstract][Full Text] [Related]
12. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
Olsson AG; Ekelund LG; Carlson LA
Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
Miyake N; Iizuka K
Rinsho Byori; 2002 Jun; 50(6):605-12. PubMed ID: 12166081
[TBL] [Abstract][Full Text] [Related]
14. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
[TBL] [Abstract][Full Text] [Related]
15. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
16. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
19. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
